Skip to main content
SpringerLink
Log in

Continuous Ambulatory Peritoneal Dialysis in Diabetic End Stage Renal Disease

  • Chapter
International Yearbook of Nephrology 1991

Part of the book series: International Yearbook of Nephrology 1991 ((IYNE,volume 3))

  • 43 Accesses

Abstract

The management of the diabetic patients with end stage renal disease (ESRD) has undergone significant changes over the last 20 years. In the beginning, diabetics were not even considered for dialysis because of their extensive co-morbidity from other systemic diseases. Early attempts to treat these patients with chronic hemodialysis were faced with disappointing results (1). Intermittent peritoneal dialysis (IPD) performed either in hospital or at home with a cycler over 30-40 hours/week, had certain advantages such as the decline or even arrest of the deterioration of neuropathy and retinopathy. However, when the residual kidney function was no longer present, this dialysis was not adequate and the majority of patients were dying from either electrolytic abnormalities or cardiovascular complications. This high mortality make IPD an unattractive treatment for the diabetic patient with ESRD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kjellstrand CM: Dialysis in diabetes. In: “Strategy in Renal Failure”, EA Friedman (Ed), J. Wiley & Sons, New York, 1977, pp 345–391.

    Google Scholar 

  2. Kjellstrand CM: A comparison of dialysis and transplantation in patients with end-stage renal failure of diabetes. In: “Diabetic Renal-Retinal Syndrome” EA Friedman and FA L’Esperance (Eds), Grune & Stratton, Orlando, Florida, 1985, pp 333–340.

    Google Scholar 

  3. Tenckhoff H, Schechter H: A bacteriologically safe peritoneal access device. Trans ASAIO, 14:181, 1968.

    Google Scholar 

  4. Khanna R, Twardowski ZJ: Peritoneal Dialysis. In: “Peritoneal Dialysis”, KD Nolph (Ed), Kluwer Academic Publishers, Dordrecht, The Netherlands, 1989, pp 319–343.

    Chapter  Google Scholar 

  5. Ponce SP, Pierratos A, Izatt, Mathews R, Khanna R, Zellerman G, Oreopoulos DG: Comparison of the survival and complications of three permanent peritoneal dialysis catheters. Perit Dial Bull, 2: 82,1982.

    Google Scholar 

  6. Lindblad AS, Novak JW, Nolph KD, Stablein DM, Cutler SJ, Steinberg SM, Vena DA: In “Continuous Ambulatory Peritoneal Dialysis in the USA”, Kluwer Academic Publishers, Dordrecht, The Netherlands, 1989, pp 63–74.

    Book  Google Scholar 

  7. Katirtzoglou A, Izatt S, Oreopoulos DG: Chronic peritoneal dialysis in diabetics with end-stage renal failure. In: “Diabetic Renal-Retinal Syndrome”, EA Friedman (Ed), Grune & Stratton, Orlando, 1982, pp. 317–332.

    Google Scholar 

  8. Blumenkrantz MJ, Shapiro DJ, Minura N, Oreopoulos DG, Friedler RM, Levin S, Tenckhoff H, Coburn JW: Maintenance peritoneal dialysis as an alternative in the patients with diabetes mellitus and end-stage uremia. Kidney Int, 6(Suppl 1): S108,1974.

    Google Scholar 

  9. Quelhorst E, Schuenemann B, Mietzsch G, Jacob I: Hemo-and peritoneal dialysis treatment of patients with diabetic nephropathy. A comparative study. Proc of EDTA, 15: 205,1978.

    CAS  Google Scholar 

  10. Mion C, Slingeneyer A, Salem JL, Oules R, Mirouze J: Home peritoneal dialysis in end stage diabetic nephropathy. J of Dialysis, 2: 426–427,1978.

    Google Scholar 

  11. Warden GS, Maxwell JG, Stephen RL: The use of reciprocating peritoneal dialysis with a subcutaneous peritoneal dialysis in end stage renal failure in dialbetes mellitus. J Surg Res, 24: 495–500, 1978.

    Article  PubMed  CAS  Google Scholar 

  12. Twardowski ZJ: New approaches to peritoneal dialysis. In: “Peritoneal Dialysis”, KD Nolph (Ed), Kluwer Academic Publishers, Dordrecht, The Netherlands, 1989,pp 133–151.

    Chapter  Google Scholar 

  13. Diaz-Buxo JA: Continuous cyclic peritoneal dialysis. In: “Dialysis”, KD Nolph (Ed), Kluwer Academic Publishers, Dordrecht, The Netherlands, 1989, pp 169–183.

    Google Scholar 

  14. Amair P, Khanna R, Leibel B, Pierratos A, Vas S, Meema G, Chisholm L, Vas M, Zingg W, Digenis G, Oreopoulos D: Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. N Engl J Med, 306: 625,1982.

    Article  PubMed  CAS  Google Scholar 

  15. Perras ST, Zappacosta AR: Reduction of peritonitis with patients education and Travenol CAPD germicidal exchange system. Am Nephrol Nurses Ass, 13: 219,1986.

    CAS  Google Scholar 

  16. Hamilton RW: The sterile connection device: A review of its development and status report-1986. In: “Advances in Continuous Ambulatory Peritoneal Dialysis”, R Khanna, KD Nolph, BF Prowant, et al (Eds) Peritoneal Dialysis Bulletin, Inc., Toronto, 1986, pp 186–189.

    Google Scholar 

  17. Fenton SSA, Wu G, Bowman C, Cattran DC, Manuel A, Khanna R, Vas S, Oreopoulos DG: The reduction in the peritonitis rate among high-risk CAPD patients with the use of the Oreopoulos-Zellerman connector. Trans ASAIO, 31: 560,1985.

    CAS  Google Scholar 

  18. Buoncristiani U, Quintalinani G, Cozzari M, Carobia C: Current status of the Y-set. In: “Advances in Continuous Ambulatory Peritoneal Dialysis”, R Khanna, et al (Eds), Peritoneal Dialysis Bulletin Inc., Toronto, 1986, pp 165–171.

    Google Scholar 

  19. Flynn CT: The diabetics on CAPD. In: “ Renal-Retinal Syndrome”, EA Friedman (Ed) Grune & Stratton, Orlando, 1982, pp 321–330.

    Google Scholar 

  20. Stout RW: Diabetes and atherosclerosis-The role of insulin. Diabetologia, 16: 141,1979.

    Article  PubMed  CAS  Google Scholar 

  21. Zavaroni A, Bonora E, Pagliara M, Dall’Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G: Risk factor for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med, 320: 702–706, 1989.

    Article  PubMed  CAS  Google Scholar 

  22. Bazzato G, Coli U, Landini S: Zylitol and low doses of insulin: New perspectives for diabetic uremic patients on CAPD. Perit Dial Bull, 2: 161,1982.

    Google Scholar 

  23. Williams FP, Marliss EB, Anderson GH, et al: Amino acids absorption following intraperitoneal administration in CAPD patients. Perit Dial Bull, 2: 124,1982.

    Google Scholar 

  24. Twardowski ZJ, Khanna R, Nolph KD: Osmotic agents and ultrafiltration in peritoneal dialysis. Nephron, 42: 93,1986.

    Article  PubMed  CAS  Google Scholar 

  25. Mistry CD, Mallick NP, Gokal R: The use of large molecular weight glucose polymer as an osmotic agent in CAPD. In: “Advances in Continuous Ambulatory Peritoneal Dialysis”, R Khanna, KD Nolph, BF Prowant, et al (Eds), Peritoneal Dialysis Bulletin, Inc., Toronto, 1986, pp7–11.

    Google Scholar 

  26. Matthys E, Dolkart R, Lameire N: Extended use of a glycerol containing dialysate in the treatment of diabetic CAPD patients. Perit Dial Bull, 7: 10,1987.

    Google Scholar 

  27. Felig P, Wahren J: The liver as site of insulin and glucagon action in normal, diabetic and obese humans. Israel J Med Sci, 11: 528,1975.

    PubMed  CAS  Google Scholar 

  28. Shafrir E, Bergman M, Felig P: The Endocrine Pancreas; Diabetes Mellitus. In: “Endocrinology and Metabolism”, P Felig, JD Baxter, AE Broadus, LA Froahman (Eds) McGraw-Hill Book Company, New York, 1987, Ch. 19, pp 1043–1178.

    Google Scholar 

  29. Tamborlane WV, Sherwin RS, Genel M, Felig P: Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable pump. N Engl J Med, 300: 573,1979.

    Article  PubMed  CAS  Google Scholar 

  30. Greenwood RH, Davies CJ, Senator GB, O’Brien I, Hayes TM: The transport of peptide hormones across the peritoneal membrane in man. Clin Sci, 57: 28,1979.

    Google Scholar 

  31. Schade DS, Eaton RP: The peritoneum-a potential insulin delivery route for a mechanical pancreas. Diabetes Care, 3: 229,1980.

    Article  PubMed  CAS  Google Scholar 

  32. Rasio EA, Hampers CL, Soeldner JS, Cahill GF: Diffusion of glucose, insulin, insulin and Evans blue protein into thoracic duct lymph of man. J Clin Invest, 46: 903,1967.

    Article  PubMed  CAS  Google Scholar 

  33. Rubin J, Reed V, Adair C, Bower J, Klein E: Effect of intraperitoneal insulin on solute kinetics in CAPD: Insulin kinetics in CAPD. Am J Med Sci, 291: 81, 1986.

    Article  PubMed  CAS  Google Scholar 

  34. Rubin J, Bell AH, Andrews M, Jones Q, Planch A: Intraperitoneal insulin-A dose response curve. Trans ASAIO, 35: 17–21,1989.

    Article  CAS  Google Scholar 

  35. Shapiro DJ, Blumenkrantz MJ, Levin SR, Cobum W: Absorption and action of insulin added to peritoneal dialysate in dogs. Nephron, 23:174,1979.

    Google Scholar 

  36. Wideroe T, Smeby LC, Berg KJ, Jorstad S, Svartas IM: Intraperitoneal insulin absorption during intermittent and continuous peritoneal dialysis. Kidney Int, 23: 22,1983.

    Article  PubMed  CAS  Google Scholar 

  37. Henderson IS, Patterson KR, Leung ACT: Decreased intraperitoneal insulin requirements during peritonitis on continuous ambulatory peritoneal dialysis. Br Med J, 290: 474,1985.

    Article  Google Scholar 

  38. Rottembourg J, El Shahat Y, Agrafiotis A, Thuillier Y, de Groc F, Jacobs C, Legrain M: Continuous ambulatory peritoneal dialysis in insulin dependent diabetics: A 40 months experience. Kidney Int, 23: 40,1983.

    Article  PubMed  CAS  Google Scholar 

  39. Harrison NA, Rainford DJ: Intraperitoneal insulin and the malignant omentum syndrome. Nephrol Dial Transplant, 3: 103,1988.

    PubMed  CAS  Google Scholar 

  40. Madden MA, Zimmerman SW, Simpson DP: CAPD in diabetes mellitus-the risks and benefits of intraperitoneal insulin. Am J Nephrol, 2: 133, 1982.

    Article  PubMed  CAS  Google Scholar 

  41. Wing AF, Broyer M, Brunner FP, et al: Combined report on regular dialysis and transplantation in Europe 1982. Proc EDTA-ERA, 20: 1, 1983.

    Google Scholar 

  42. Williams C and the University of Toronto Collaborative Dialysis Group: CAPD in Toronto-an overview. Perit Dial Bull, 35: 2,1983.

    Google Scholar 

  43. Nolph KD, Stolta M, Maher JF: Altered peritoneal permeability in patients with systemic vasculitis. Ann Intern Med, 78: 891,1973.

    PubMed  Google Scholar 

  44. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Neilsen P: Peritoneal equilibration test. Perit Dial Bull, 7: 138,1987.

    Google Scholar 

  45. Gilmore J, Wu G, Khanna R, Oreopoulos DG: Long term CAPD. Perit Dial Bull, 5: 112, 1985.

    Google Scholar 

  46. Zimmerman SW, Johnson CA, O’Brien M: Survival of diabetic patients on continuous ambulatory peritoneal dialysis for over five years. Perit Dial Bull, 7: 26,1987.

    Google Scholar 

  47. Vas SI: Peritonitis. In: “Peritoneal Dialysisℍ, KD Nolph (Ed), Kluwer Academic Publishers, Dordrecht, The Netherlands, 1989, pp 261–288.

    Chapter  Google Scholar 

  48. Nolph KD, Cutler SJ Steinberg SM, Novak JW: Special studies from the NIH USA CAPD Registry. Perit Dial Bull, 6: 28–35, 1986.

    Google Scholar 

  49. Rottembourg J, Brouard R, Issad B, Allouache M, Jacobs C: Prospective randomized study about Y connectors in CAPD patients. In: “Advances in Continuous Ambulatory Peritoneal Dialysis”, R Khanna, KD Nolph, BF Prowant, ZJ Twardowski and DG Oreopoulos (Eds), Peritoneal Dialysis Bulletin, Inc., Toronto, 1987, pp 107–113.

    Google Scholar 

  50. Faller B, Marichal JD: Loss of ultrafiltration in CAPD. Clinical Data. In: “Advances in Peritoneal Dialysis”, G Gahl, M Kessel and KD Nolph (Eds), Excerpta Medica, Amsterdam, 1981, pp 227–232.

    Google Scholar 

  51. Slingeneyer A, Mion C, Mourad G, Canaud B, Faller B & Beraud JJ: Progressive sclerozing peritonitis: A late and severe complications of maintenance peritoneal dialysis. Trans ASAIO, 29: 633, 1983.

    CAS  Google Scholar 

  52. Rottembourg J, Brouard R, Issad B, Allouache M, Ghali B & Boudjemaa A: Role of acetate in loss of ultrafiltration during CAPD. In: “Contribution to Nephrology”, GM Berlyne and S Giovannetti (Eds), S. Karger AG, Switzerland, 1987, p 197.

    Google Scholar 

  53. Norbeck H: Lipid abnormalities in continuous ambulatory peritoneal dialysis patients. In: “Continuous Ambulatory Peritoneal Dialysis”, M Legrain (Ed), Excerpta Medica, Amsterdam. 1979, pp 298–301.

    Google Scholar 

  54. Khanna R, Brechenridge C, Roncari D, Digenis G, Oreopoulos DG: Lipid abnormalities in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Bull, 3: 13–16,1983.

    Google Scholar 

  55. Norbeck H, Oro L, Carlson LA: Serum lipid and lipoprotein concentrations in chronic uremia. Acta Med Scand, 200:487–495,1976.

    Article  PubMed  CAS  Google Scholar 

  56. Kagan A, Barkhayim Y, Schafer Z, Fainaru, M: Low level of plasma HDL in CAPD patients may be due to HDL loss in dialysate. Peritoneal Dial Internat, A: 79,1988 (abstract).

    Google Scholar 

  57. Diaz-Buxo JA, Burgess WP, Greenman M, Chandler JT, Farmer CD, Walker PJ: Visual function in diabetic patients undergoing dialysis: Comparison of peritoneal and hemodialysis. Internat J Artif Organs, 7: 257,1984.

    CAS  Google Scholar 

  58. Rottembourg J, Bellio P, Maiga K, Remaoun M, Rousselie F & Legrain M: Visual function, blood pressure and blood glucose in diabetic patients undergoing continuous ambulatory peritoneal dialysis. Proc EDTA, 21: 330,1984.

    Google Scholar 

  59. Khanna R, Wu G, Prowant B, Jastrzebska J, Nolph KD, Oreopoulos DG: A combined experience of two North American centers. In: “Diabetic Renal-Retinal Syndrome”, EA Friedman and FA L’Esperance, Jr (Eds), Grune & Stratton, Orlando, 1986, pp 363–382.

    Google Scholar 

  60. Rottembourg J, Issad B, Poignet JL, et al: Residual renal function and control of blood glucose levels in insulin-dependent diabetic patients treated by CAPD. In: “Prevention and Treatment of Diabetic Nephropathy”, H Keen and M Legrain (Eds), MTP Press Ltd, Boston, 1983, pp 339–352.

    Google Scholar 

  61. Cancarini GC, Brunori G, Camerini C, Brasa S, Manili L, Maiorca R: Renal function recovery and maintenance of residual diuresis in CAPD and hemodialysis. Perit Dial Bull 6: 77–79,1986.

    Google Scholar 

  62. Lysaght M, Pollock C, Schindaglm K, Ibeles L, Farrell P: The relevance of urea kinetic modeling to CAPD. ASAIO, Abstracts, 34: 84,1988.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, University of Missouri, Columbia and Toronto Western Hospital, Toronto, Ontario, Canada

    Ramesh Khanna & Dimitrios G. Oreopoulos

Authors
  1. Ramesh Khanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dimitrios G. Oreopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Nephrology, University of Naples, Naples, Italy

    Vittorio E. Andreucci

  2. Division of Nephrology, UCLA School of Medicine, University of California, Los Angeles, California, USA

    Leon G. Fine

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Khanna, R., Oreopoulos, D.G. (1990). Continuous Ambulatory Peritoneal Dialysis in Diabetic End Stage Renal Disease. In: Andreucci, V.E., Fine, L.G. (eds) International Yearbook of Nephrology 1991. International Yearbook of Nephrology 1991, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3946-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3946-9_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6761-1

  • Online ISBN: 978-1-4615-3946-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation